Diagnosis & Disease Information

CDC Investigating Artificial Tears Product Linked to Drug-Resistant Infections

The Centers for Disease Control and Prevention (CDC) is urging health care providers and patients to immediately discontinue use of EzriCare Artificial Tears as the Agency is currently investigating its link to multiple different infection types, including eye infections. From May 17, 2022 to January 19, 2023, the CDC, alongside state and local health departments,…

MPR Weekly Dose Podcast #139

FDA pulls bebtelovimab EUA; compounding guidance issued in light of the amoxicillin shortage; the first fecal microbiota treatment is approved; a treatment for Alzheimer disease agitation shows promise; and a gene therapy for Duchenne muscular dystrophy is accepted for Priority Review.